GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Catalent Inc (NYSE:CTLT) » Definitions » Shiller PE Ratio

Catalent (Catalent) Shiller PE Ratio : 69.41 (As of Apr. 29, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Catalent Shiller PE Ratio?

As of today (2024-04-29), Catalent's current share price is $56.22. Catalent's E10 for the quarter that ended in Dec. 2023 was $0.81. Catalent's Shiller PE Ratio for today is 69.41.

The historical rank and industry rank for Catalent's Shiller PE Ratio or its related term are showing as below:

CTLT' s Shiller PE Ratio Range Over the Past 10 Years
Min: 23.81   Med: 58.98   Max: 148.87
Current: 69.41

During the past years, Catalent's highest Shiller PE Ratio was 148.87. The lowest was 23.81. And the median was 58.98.

CTLT's Shiller PE Ratio is ranked worse than
87.62% of 525 companies
in the Drug Manufacturers industry
Industry Median: 24.63 vs CTLT: 69.41

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Catalent's adjusted earnings per share data for the three months ended in Dec. 2023 was $-1.130. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $0.81 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Catalent Shiller PE Ratio Historical Data

The historical data trend for Catalent's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Catalent Shiller PE Ratio Chart

Catalent Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 80.87 32.72

Catalent Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.80 47.68 32.72 50.29 55.58

Competitive Comparison of Catalent's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Catalent's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Catalent's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Catalent's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Catalent's Shiller PE Ratio falls into.



Catalent Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Catalent's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=56.22/0.81
=69.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Catalent's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Catalent's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-1.13/129.4194*129.4194
=-1.130

Current CPI (Dec. 2023) = 129.4194.

Catalent Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 0.057 99.695 0.074
201406 0.232 100.560 0.299
201409 -0.180 100.428 -0.232
201412 0.370 99.070 0.483
201503 0.250 99.621 0.325
201506 1.220 100.684 1.568
201509 0.090 100.392 0.116
201512 0.240 99.792 0.311
201603 0.090 100.470 0.116
201606 0.460 101.688 0.585
201609 0.040 101.861 0.051
201612 0.140 101.863 0.178
201703 0.210 102.862 0.264
201706 0.490 103.349 0.614
201709 0.030 104.136 0.037
201712 -0.160 104.011 -0.199
201803 0.140 105.290 0.172
201806 0.610 106.317 0.743
201809 -0.100 106.507 -0.122
201812 0.330 105.998 0.403
201903 0.220 107.251 0.265
201906 0.440 108.070 0.527
201909 -0.050 108.329 -0.060
201912 0.230 108.420 0.275
202003 0.080 108.902 0.095
202006 0.850 108.767 1.011
202009 0.410 109.815 0.483
202012 0.450 109.897 0.530
202103 1.260 111.754 1.459
202106 0.970 114.631 1.095
202109 0.490 115.734 0.548
202112 0.520 117.630 0.572
202203 0.780 121.301 0.832
202206 1.040 125.017 1.077
202209 0.000 125.227 0.000
202212 0.440 125.222 0.455
202303 -1.260 127.348 -1.280
202306 -0.480 128.729 -0.483
202309 -4.190 129.860 -4.176
202312 -1.130 129.419 -1.130

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Catalent  (NYSE:CTLT) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Catalent Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Catalent's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Catalent (Catalent) Business Description

Traded in Other Exchanges
Address
14 Schoolhouse Road, Somerset, NJ, USA, 08873
Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenues primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products throughout the entire life cycle of a product from the drug development process to commercial supply. Catalent has over 50 facilities across four continents.
Executives
David Mcerlane officer: Group President, Biologics C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873
Steven Barg director ELLIOTT MANAGEMENT CORPORATION, 40 WEST 57TH STREET, NEW YORK NY 10019
Michelle R Ryan director 214 PARK BLVD S, VENICE FL 34285
John J Greisch director C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873
Stephanie Okey director C/O ALBIREO PHARMA, INC., 10 POST OFFICE SQUARE, SUITE 502 SOUTH, BOSTON MA 02109
Frank A Damelio director C/O PFIZER INC., 235 EAST 42ND ST., NEW YORK NY 10017
Aristippos Gennadios officer: See Remarks C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873
Thomas W Hawkeswood officer: Pres. Pharma Prod Delivery Div C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873
Patricia Hunt officer: Pres. Consumer Health Div C/O CATALENT, 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873
Ricky Hopson officer: VP, Chief Accounting Officer CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873
Lorenzo Carletti officer: SVP Global Ops Small Molecule C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873
Ricardo Pravda officer: SVP, Human Resources C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873
Alessandro Maselli officer: See remarks C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873
Charles Lickfold officer: SVP, CIO C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873
Scott Gunther officer: See Remarks C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873

Catalent (Catalent) Headlines

From GuruFocus

Q4 2021 Catalent Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Catalent Inc at Stephens Investment Conference Transcript

By GuruFocus Research 01-22-2024

Catalent Inc Investor Presentation Transcript

By GuruFocus Research 01-22-2024

Q3 2023 Catalent Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q4 2023 Catalent Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Catalent Inc at Jefferies Healthcare Conference Transcript

By GuruFocus Research 01-22-2024